- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- October 2024
- 195 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
Pindolol is a beta-blocker drug used in the treatment of cardiovascular diseases. It is used to treat hypertension, angina, and arrhythmias. It works by blocking the action of certain hormones in the body, such as epinephrine, which can cause an increase in blood pressure. Pindolol is also used to treat certain types of heart failure, and to reduce the risk of death after a heart attack. It is available in both oral and injectable forms.
Pindolol is marketed by several pharmaceutical companies, including Merck, Pfizer, and Novartis. It is also available in generic form from several generic drug manufacturers. Pindolol is available in many countries around the world, including the United States, Canada, Europe, and Australia.
Companies in the Pindolol market include Merck, Pfizer, Novartis, Mylan, Teva, Sandoz, and Sun Pharmaceuticals. Show Less Read more